| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Health economics of dengue: a systematic literature review and expert panel's assessment.
|
Am J Trop Med Hyg
|
2011
|
2.05
|
|
2
|
Dengue incidence in urban and rural Cambodia: results from population-based active fever surveillance, 2006-2008.
|
PLoS Negl Trop Dis
|
2010
|
1.98
|
|
3
|
Determinants of malaria prophylaxis among German travelers to Kenya, Senegal, and Thailand.
|
J Travel Med
|
2008
|
1.62
|
|
4
|
Communicable diseases prioritized for surveillance and epidemiological research: results of a standardized prioritization procedure in Germany, 2011.
|
PLoS One
|
2011
|
1.45
|
|
5
|
Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population.
|
J R Soc Interface
|
2010
|
1.35
|
|
6
|
Cost of dengue and other febrile illnesses to households in rural Cambodia: a prospective community-based case-control study.
|
BMC Public Health
|
2009
|
1.27
|
|
7
|
The efficacy and duration of vaccine protection against human papillomavirus: a systematic review and meta-analysis.
|
Dtsch Arztebl Int
|
2014
|
1.26
|
|
8
|
Monitoring pandemic influenza A(H1N1) vaccination coverage in Germany 2009/10 - results from thirteen consecutive cross-sectional surveys.
|
Vaccine
|
2011
|
1.21
|
|
9
|
Human Papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling.
|
BMC Infect Dis
|
2014
|
1.12
|
|
10
|
Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany.
|
BMC Public Health
|
2012
|
1.09
|
|
11
|
Seasonal influenza vaccine uptake in Germany 2007/2008 and 2008/2009: results from a national health update survey.
|
Vaccine
|
2011
|
1.09
|
|
12
|
Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany.
|
Eur J Health Econ
|
2012
|
1.05
|
|
13
|
Molecular surveillance of drug resistance through imported isolates of Plasmodium falciparum in Europe.
|
Malar J
|
2002
|
1.04
|
|
14
|
Determinants of tetanus and seasonal influenza vaccine uptake in adults living in Germany.
|
Hum Vaccin
|
2011
|
1.02
|
|
15
|
Closer to the goal: efforts in measles elimination in Germany 2010.
|
J Infect Dis
|
2011
|
1.01
|
|
16
|
Herpes zoster in Germany: quantifying the burden of disease.
|
BMC Infect Dis
|
2011
|
0.99
|
|
17
|
Molecular surveillance of circulating dengue genotypes through European travelers.
|
J Travel Med
|
2011
|
0.92
|
|
18
|
Molecular and serologic markers of acute dengue infection in naive and flavivirus-vaccinated travelers.
|
Diagn Microbiol Infect Dis
|
2009
|
0.92
|
|
19
|
Human papillomavirus vaccine uptake, knowledge and attitude among 10th grade students in Berlin, Germany, 2010.
|
Hum Vaccin Immunother
|
2012
|
0.91
|
|
20
|
Will dengue vaccines be used in the public sector and if so, how? Findings from an 8-country survey of policymakers and opinion leaders.
|
PLoS Negl Trop Dis
|
2013
|
0.91
|
|
21
|
Rotavirus vaccine effectiveness and case-control study on risk factors for breakthrough infections in Germany, 2010-2011.
|
Pediatr Infect Dis J
|
2013
|
0.90
|
|
22
|
Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany.
|
BMC Health Serv Res
|
2013
|
0.89
|
|
23
|
Knowledge, attitude, and uptake related to human papillomavirus vaccination among young women in Germany recruited via a social media site.
|
Hum Vaccin Immunother
|
2014
|
0.89
|
|
24
|
Evidence-based decision-making in infectious diseases epidemiology, prevention and control: matching research questions to study designs and quality appraisal tools.
|
BMC Med Res Methodol
|
2014
|
0.88
|
|
25
|
Epidemiology of invasive meningococcal disease in Germany, 2002-2010, and impact of vaccination with meningococcal C conjugate vaccine.
|
J Infect
|
2012
|
0.87
|
|
26
|
HPV vaccination coverage among women aged 18-20 years in Germany three years after recommendation of HPV vaccination for adolescent girls: results from a cross-sectional survey.
|
Hum Vaccin Immunother
|
2013
|
0.87
|
|
27
|
Forecasting dengue vaccine demand in disease endemic and non-endemic countries.
|
Hum Vaccin
|
2010
|
0.87
|
|
28
|
Effectiveness of the AS03-adjuvanted vaccine against pandemic influenza virus A/(H1N1) 2009--a comparison of two methods; Germany, 2009/10.
|
PLoS One
|
2011
|
0.86
|
|
29
|
Risk and spectrum of diseases in travelers to popular tourist destinations.
|
J Travel Med
|
2005
|
0.85
|
|
30
|
Effectiveness and timing of vaccination during school measles outbreak.
|
Emerg Infect Dis
|
2012
|
0.85
|
|
31
|
Vaccines for the prevention of seasonal influenza in patients with diabetes: systematic review and meta-analysis.
|
BMC Med
|
2015
|
0.83
|
|
32
|
Seroprevalence study of Francisella tularensis among hunters in Germany.
|
FEMS Immunol Med Microbiol
|
2008
|
0.82
|
|
33
|
Risk factors for cervical human papillomavirus infection and high-grade intraepithelial lesion in women aged 20 to 31 years in Germany.
|
Int J Gynecol Cancer
|
2013
|
0.82
|
|
34
|
Impact of rotavirus vaccination in regions with low and moderate vaccine uptake in Germany.
|
Hum Vaccin Immunother
|
2012
|
0.82
|
|
35
|
Antibodies against Rickettsia spp. in hunters, Germany.
|
Emerg Infect Dis
|
2008
|
0.80
|
|
36
|
Evaluation of a temporary vaccination recommendation in response to an outbreak of invasive meningococcal serogroup C disease in men who have sex with men in Berlin, 2013-2014.
|
Euro Surveill
|
2016
|
0.80
|
|
37
|
Lessons from a one-year hospital-based surveillance of acute respiratory infections in Berlin- comparing case definitions to monitor influenza.
|
BMC Public Health
|
2012
|
0.79
|
|
38
|
Report on the 1st international workshop on procedures for the development of evidence-based vaccination recommendations, Berlin, Germany, 22-23 November 2010.
|
Vaccine
|
2011
|
0.79
|
|
39
|
Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls.
|
BMC Infect Dis
|
2012
|
0.77
|
|
40
|
Bayesian parameter inference for dynamic infectious disease modelling: rotavirus in Germany.
|
Stat Med
|
2014
|
0.76
|
|
41
|
Effectiveness of routine and booster pertussis vaccination in children and adolescents, federal state of Brandenburg, Germany, 2002-2012.
|
Pediatr Infect Dis J
|
2015
|
0.76
|
|
42
|
[Polio vaccination: a commentary].
|
Dtsch Med Wochenschr
|
2016
|
0.75
|
|
43
|
Marked Under-Reporting of Pertussis Requiring Hospitalization in Infants as Estimated by Capture-Recapture Methodology, Germany, 2013-2015.
|
Pediatr Infect Dis J
|
2017
|
0.75
|
|
44
|
Risk of Intussusception After Rotavirus Vaccination.
|
Dtsch Arztebl Int
|
2017
|
0.75
|
|
45
|
[From the licensure of vaccines to the recommendation of the Standing Committee on Vaccination in Germany : criteria for the assessment of benefits and risks].
|
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
|
2015
|
0.75
|